Skip to main content
. 2021 Dec 11;11(12):2336. doi: 10.3390/diagnostics11122336

Figure 2.

Figure 2

(a) Frequency of comorbidities (CMB) in the cohort of patients. (b) Frequency of number of drugs regularly assumed by HCV/HIV co-infected patients (ART not included).